Navigation Links
The American Society of Hematology Elects New Leadership
Date:11/3/2009

WASHINGTON, Nov. 3 /PRNewswire-USNewswire/ -- The American Society of Hematology, the world's largest professional society of blood specialists, welcomes five new officers to its Executive Committee, the governing body of the organization. The officers will begin serving their terms in January 2010.

Armand Keating, MD, will serve a one-year term as vice-president, followed by successive terms as president-elect and president. New councillors Marilyn J. Telen, MD, and Kenneth C. Anderson, MD, will serve four-year terms, and Mohandas Narla, DSc, will serve as councillor for a one-year term. These individuals are well-respected hematologists and active members of the Society.

Dr. Keating is Professor of Medicine and Director, Division of Hematology, Epstein Chair in Cell Therapy and Transplantation, University of Toronto, and Director, Cell Therapy Program, Princess Margaret Hospital, Toronto. His clinical and research interests focus on anti-cancer cell therapy, blood and marrow transplantation, leukemia, lymphoma, and cell-based tissue regeneration. He has conducted laboratory, translational, and clinical research in cell therapy, normal and leukemic hematopoiesis, and the biology and clinical application of mesenchymal stromal cells.

Dr. Telen, Wellcome Professor of Medicine and Chief, Division of Hematology, Duke University Medical Center, is recognized as an expert in the biochemistry and molecular genetics of blood group antigens and the pathophysiological mechanisms of vaso-occlusion in sickle cell disease. She is the director of the Duke Comprehensive Sickle Cell Center.

Dr. Anderson, Kraft Family Professor of Medicine, Harvard Medical School, Dana-Farber Cancer Institute (DFCI), is Chief of the Division of Hematologic Neoplasia, Director of the Lipper Myeloma Center and Lebow Institute for Myeloma Therapeutics, and Vice Chair of the Joint Program in Transfusion Medicine at DFCI. His area of research is novel biologically based therapies for multiple myeloma.

Dr. Narla, Vice President for Research, New York Blood Center, is the Director of the Lindsley F. Kimball Research Institute and heads the Laboratory of Red Cell Physiology at New York Blood Center. His primary research focus is the study of the structural organization of blood cell membranes in health and disease and on regulation of blood cell production.

Reporters who wish to arrange an interview may contact Patrick C. Irelan, ASH Communications Assistant, at 202-776-0544 or pirelan@hematology.org.

The American Society of Hematology (www.hematology.org) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. ASH provides Blood: The Vital Connection (www.bloodthevitalconnection.org), a credible online resource addressing bleeding and clotting disorders, anemia, and cancer. The official journal of ASH is Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online.

SOURCE American Society of Hematology


'/>"/>
SOURCE American Society of Hematology
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Many Older Americans Have Active Sex Lives
2. Despite grumbling, most Americans say they are happy at work
3. Record Number of Americans Lack Health Insurance
4. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
5. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
6. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
7. Novo Nordisk Appoints New Leader of North American Business
8. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
9. Primary biliary cirrhosis more severe in African-American and Hispanic patients
10. AOA President Calls on Congress to Reauthorize SCHIP and Take Action to Ensure Health Care Coverage for All Americans
11. American Chemical Societys Weekly Presspac -- Sept. 5, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
Breaking Medicine Technology: